U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934

                For the quarterly period ended July 31, 2005

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

                         For the transition period from

                          Commission File No. 000-51509

                              Elite Cosmetics, Inc.
        (Exact name of small business issuer as specified in its charter)

       Delaware
(State or other jurisdiction of                           (I.R.S. Employer
incorporation or organization)                           Identification No.)

                            107 St. Patrick's Street
                            Donaldsonville, Louisiana 70346
                    (Address of Principal Executive Offices)

                                  225/473-7578
                           (Issuer's telephone number)


      (Former name, address and fiscal year, if changed since last report)

Check  whether  the issuer  (1) has filed all  reports  required  to be filed by
Section 13 or 15(d) of the Exchange  Act during the  preceding 12 months (or for
such shorter period that the issuer was required to file such reports),  and (2)
has been subject to such filing requirements for the past 90 days. Yes [X] No[ ]

Indicate by a check mark whether, The Registrant is a shell company (as defined
in Rule 12b-2 at the Exchange Act) Yes[ ] No [X]

Check whether the registrant has filed all documents and reports  required to be
filed by  Sections  12,  13,  or 15(d) of the  Exchange  Act  subsequent  to the
distribution of securities under a plan confirmed by a court. Yes [X] No [ ]

State the number of shares outstanding of each of the issuer's classes of common
equity, as of September 13, 2005: 28,870,000 shares of common stock.

<PAGE>

                                 Elite Cosmetics, Inc.
                          (a development stage company)

                              FINANCIAL STATEMENTS

                                      INDEX


Part I-- FINANCIAL INFORMATION

  Item 1. Financial Statements

  Item 2. Management's Discussion and Analysis of Financial Condition

  Item 3. Control and Procedures

Part II-- OTHER INFORMATION

  Item 1. Legal Proceedings

  Item 2. Changes in Securities

  Item 3. Defaults Upon Senior Securities

  Item 4. Submission of Matters to a Vote of Security Holders

  Item 5. Other Information

  Item 6. Exhibits and Reports on Form 8-K

Signature


<PAGE>
Item 1. Financial Information
-----------------------------

BASIS OF PRESENTATION

The accompanying  reviewed financial statements are presented in accordance with
U.S. generally accepted accounting  principles for interim financial information
and the  instructions  to Form 10-QSB and item 310 under subpart A of Regulation
S-B.  Accordingly,  they do not include  all of the  information  and  footnotes
required by generally  accepted  accounting  principles  for complete  financial
statements.  In the opinion of management,  all adjustments  (consisting only of
normal occurring accruals)  considered  necessary in order to make the financial
statements not misleading,  have been included.  Operating  results for the nine
months ended July 31, 2005 are not necessarily indicative of results that may be
expected for the year ending  October 31, 2005.  The  financial  statements  are
presented on the accrual basis.

<PAGE>

                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                              FINANCIAL STATEMENTS
                               AS OF JULY 31, 2005
                                   (UNAUDITED)



<PAGE>
                             ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)



                                    CONTENTS


PAGE                1       CONDENSED BALANCE SHEET AS OF JULY 31, 2005
                            (UNAUDITED)

PAGE                2       CONDENSED  STATEMENTS OF  OPERATIONS  FOR THE THREE
                            AND NINE MONTHS ENDED JULY 31, 2005
                            AND FOR THE PERIOD FROM AUGUST 19, 2004 (INCEPTION)
                            TO JULY 31, 2005 (UNAUDITED)

PAGE                3       CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS'
                            DEFICIENCY FOR THE PERIOD FROM AUGUST  19, 2004
                            (INCEPTION) TO JULY 31, 2005 (UNAUDITED)

PAGE                4       CONDENSED  STATEMENTS OF CASH FLOWS FOR THE NINE
                            MONTHS ENDED JULY 31, 2005 AND FOR THE PERIOD FROM
                            AUGUST 19, 2004 (INCEPTION) TO JULY 31, 2005
                            (UNAUDITED)

PAGES             5 - 8     NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)



<PAGE>
                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                             CONDENSED BALANCE SHEET
                               AS OF JULY 31, 2005
                               -------------------
                                   (UNAUDITED)

<TABLE>
<CAPTION>

                                     ASSETS
                                     ------
<S>                                                                                                    <C>
CURRENT ASSETS
  Cash                                                                                        $           19,696
  Inventories                                                                                                255
                                                                                              -------------------

TOTAL ASSETS                                                                                  $           19,951
------------
                                                                                              ===================


                                    LIABILITIES AND STOCKHOLDERS' DEFICIENCY
                                    ----------------------------------------
CURRENT LIABILITIES
  Loans payable - stockholder                                                                 $           36,118
                                                                                              -------------------

TOTAL LIABILITIES                                                                                         36,118
-----------------
                                                                                              -------------------

STOCKHOLDERS' DEFICIENCY
  Common stock, $0.0001 par value, 100,000,000 shares authorized, 28,700,000 shares
   issued and outstanding                                                                                  2,887
  Additional paid in capital                                                                             861,334
  Accumulated deficit during development stage                                                          (880,388)
                                                                                              -------------------
        Total Stockholders' Deficiency                                                                   (16,167)
                                                                                              -------------------

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY                                                $           19,951
----------------------------------------------                                                ===================

</TABLE>

            See accompanying notes to condensed financial statements.

                                        1

<PAGE>
                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                       CONDENSED STATEMENTS OF OPERATIONS
                       ----------------------------------
                                   (UNAUDITED)


<TABLE>
<CAPTION>

                                                                                                           For the Period From
                                                      For the Three Months          For the Nine             August 19, 2004
                                                              Ended                 Months Ended           (Inception) to July
                                                          July 31, 2005             July 31, 2005               31, 2005
                                                      ----------------------     --------------------     ----------------------
<S>                                                             <C>                        <C>                      <C>
    OPERATING EXPENSE
      Stock compensation                              $                   -      $           852,000      $             852,000
      Professional fees                                              27,020                   27,020                     27,020
      General and administrative                                        247                      497                      1,097
                                                      ----------------------     --------------------     ----------------------
            Total Operating Expense                                  27,267                  879,517                    880,117
                                                      ----------------------     --------------------     ----------------------
    LOSS FROM OPERATIONS                                            (27,267)                (879,517)                  (880,117)

    OTHER EXPENSE
      Interest expense                                                  271                      271                        271
                                                      ----------------------     --------------------     ----------------------
             Total Other Expense                                        271                      271                        271
                                                      ----------------------     --------------------     ----------------------
    NET LOSS BEFORE TAXES                                           (27,538)                (879,788)                  (880,388)

    Provision for Income Taxes                                            -                        -                          -
                                                      ----------------------     --------------------     ----------------------
    NET LOSS                                          $             (27,538)     $          (879,788)     $            (880,388)
                                                      ======================     ====================     ======================

     Net loss per share - basic and diluted           $                   -       `            (0.07)     $
                                                      ======================     ====================
    Weighted average number of shares outstanding
     during the period - basic and diluted                       28,851,957               12,080,476
                                                      ======================     ====================

</TABLE>

            See accompanying notes to condensed financial statements.

                                        2


<PAGE>
                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                CONDENSED STATEMENTS OF STOCKHOLDERS' DEFICIENCY
        FOR THE PERIOD FROM AUGUST 19, 2004 (INCEPTION) TO JULY 31, 2005
        ----------------------------------------------------------------
                                   (UNAUDITED)

<TABLE>
<CAPTION>

                                                                                                   Accumulated
                                                                            Additional           Deficit During
                                               Common Stock                   Paid-In              Development
                                        Shares               Amount           Capital                 Stage               Total
                                   ----------------    ----------------   ----------------     ----------------     ----------------
<S>                                      <C>                  <C>                <C>                   <C>                <C>
Stock issued to founders for
 expenses ($0.0001 per share)              100,000     $            10    $            90      $             -      $           100

Net loss for the period from
 August  19, 2004 (inception)
 to October 31, 2004                             -                   -                  -                 (600)                (600)
                                   ----------------    ----------------   ----------------     ----------------     ----------------

Balance, October 31, 2004                  100,000                  10                 90                 (600)                (500)

Common stock issued for services
 ($0.03 per share)                      28,400,000               2,840            849,160                    -              852,000

Common stock issued for cash
 ($0.03 per share)                         150,000                  15              4,485                    -                4,500

In-kind contribution                             -                   -                750                    -                  750

Net loss for the six months
 ended April 30, 2005                            -                   -                  -             (852,250)            (852,250)
                                   ----------------    ----------------   ----------------     ----------------     ----------------

Balance, April 30, 2005                 28,650,000               2,865            854,485             (852,850)               4,500

Common stock issued for cash
 ($0.03 per share)                         220,000                  22              6,578                    -                6,600

In-kind contribution of
 interest expense                                -                   -                271                    -                  271

Net loss for the three
 months ended July 31, 2005                      -                   -                  -              (27,538)             (27,538)
                                   ----------------    ----------------   ----------------     ----------------     ----------------

BALANCE, JULY 31, 2005                  28,870,000     $         2,887    $       861,334      $      (880,388)     $       (16,167)
----------------------             ================    ================   =================    ================     ================
</TABLE>

            See accompanying notes to condensed financial statements.


                                        3

<PAGE>
                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                       CONDENSED STATEMENTS OF CASH FLOWS
                       ----------------------------------
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                                         For the Period From
                                                                               For the Nine Months         August 19, 2004
                                                                                    Ended                (Inception) to July
                                                                                July 31, 2005                  31, 2005
                                                                             ---------------------       ---------------------
<S>                                                                                   <C>                         <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net loss                                                                   $            (879,788)      $           (880,388)
  Adjustments to reconcile net loss to net cash used in operating
   activities:
    Stock compensation                                                                    852,000                     852,000
    In-kind contribution                                                                    1,021                       1,121
   Changes in operating assets and liabilities:
    Increase in inventories                                                                  (255)                       (255)
    Decrease in accounts payable                                                             (500)                          -
                                                                             ---------------------       ---------------------
         Net Cash Used In Operating Activities                                            (27,522)                    (27,522)
                                                                             ---------------------       ---------------------

CASH FLOWS FROM INVESTING ACTIVITIES                                                            -                           -
                                                                             ---------------------       ---------------------

CASH FLOWS FROM FINANCING ACTIVITIES:
  Proceeds from loan payable - related party                                               36,118                      36,118
  Proceeds from issuance of common stock                                                   11,100                      11,100
                                                                             ---------------------       ---------------------
         Net Cash Provided By Financing Activities                                         47,218                      47,218
                                                                             ---------------------       ---------------------

NET INCREASE IN CASH                                                                       19,696                      19,696

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD                                                -                           -
                                                                             ---------------------       ---------------------

CASH AND CASH EQUIVALENTS AT END OF PERIOD                                   $             19,696        $             19,696
                                                                             =====================       =====================

</TABLE>
            See accompanying notes to condensed financial statements.


                                        4


<PAGE>
                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                     NOTES TO CONDENSED FINANCIAL STATEMENTS
                               AS OF JULY 31, 2005
                               -------------------
                                   (UNAUDITED)


                                        8

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION
------------------------------------------------------------------

        (A) Basis of Presentation
        -------------------------

        The  accompanying  unaudited  condensed  financial  statements have been
        prepared in accordance with accounting  principles generally accepted in
        The  United  States of  America  and the rules  and  regulations  of the
        Securities and Exchange  Commission for interim  financial  information.
        Accordingly,  they do not include all the  information  necessary  for a
        comprehensive   presentation  of  financial   position  and  results  of
        operations.

        It is  management's  opinion,  however  that  all  material  adjustments
        (consisting of normal  recurring  adjustments)  have been made which are
        necessary for a fair financial statements presentation.  The results for
        the interim period are not  necessarily  indicative of the results to be
        expected for the year.

        During 2005, the Company  changed its name from Edmonds 4, Inc. to Elite
        Cosmetics, Inc. to better reflect its current business operations.

        (B) Organization
         ---------------

        Elite  Cosmetics,  Inc.  F/K/A  Edmonds  4, Inc.  (a  development  stage
        company)  (the  "Company")  was  incorporated  in Delaware on August 19,
        2004, and has elected a fiscal year end of October 31.

        The Company  plans to market a line of women's'  cosmetics.  The Company
        intends to market its products  directly to consumers  through a variety
        of direct marketing channels.

        Activities during the development stage include developing the corporate
        infrastructure, implementing the business plan, and raising capital.

        (C) Use of Estimates
         -------------------

        In preparing financial  statements in conformity with generally accepted
        accounting  principles,  management  is required to make  estimates  and
        assumptions  that affect the reported  amounts of assets and liabilities
        and the disclosure of contingent  assets and  liabilities at the date of
        the financial  statements and revenues and expenses  during the reported
        period. Actual results could differ from those estimates.


                                       5
<PAGE>
                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                     NOTES TO CONDENSED FINANCIAL STATEMENTS
                               AS OF JULY 31, 2005
                               -------------------
                                   (UNAUDITED)


        (D) Loss Per Share
         -----------------

        Basic and diluted net loss per common  share is computed  based upon the
        weighted  average  common  shares  outstanding  as defined by  Financial
        Accounting Standards No. 128, "Earnings Per Share." As of July 31, 2005,
        there were no common share equivalents outstanding.

        (E) Inventories
         --------------

        The  Company's  inventories  are  stated  at the lower of cost or market
        value,  cost being  determined  on a  first-in,  first-out  method.  The
        Company  provides  inventory  allowances  based on excess  and  obsolete
        inventories  determined  principally  by  customer  demand  and  product
        expiration dates.

        (F) Revenue
         ----------

        The Company recognizes revenue from the sale of cosmetic products at the
        time  title  to  the  products  transfers,   the  amount  is  fixed  and
        determinable, evidence of an agreement exists and the customer bears the
        risk of loss, net of estimated provisions for returns, rebates and sales
        allowances.

        (G) Advertising
         --------------

        Advertising costs are expensed as incurred.  Advertising expense totaled
        $11 for the three and nine month periods ended July 31, 2005.

        (H) Business Segments
         --------------------

        The Company operates in one segment and therefore segment information is
        not presented.

        (I) Income Taxes
         ---------------

        The Company  accounts for income taxes under the  Statement of Financial
        Accounting  Standards Board Statement of Financial  Accounting Standards
        No.  109,   "Accounting  for  Income  Taxes"  ("Statement  109").  Under
        Statement 109,  deferred tax assets and  liabilities  are recognized for
        the future tax  consequences  attributable  to  differences  between the
        financial  statement carrying amounts of existing assets and liabilities
        and their respective tax bases.  Deferred tax assets and liabilities are
        measured  using enacted tax rates expected to apply to taxable income in
        the  years in which  those  temporary  differences  are  expected  to be
        recovered or settled.  Under  Statement  109, the effect on deferred tax
        assets and  liabilities of a change in tax rates is recognized in income
        in  the  period  that  includes  the  enactment  date.

                                       6
<PAGE>
                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                     NOTES TO CONDENSED FINANCIAL STATEMENTS
                               AS OF JULY 31, 2005
                               -------------------
                                   (UNAUDITED)


        (J) Stock-Based Compensation
         ---------------------------

        The Company applies Accounting  Principles Board ("APB") Opinion No. 25,
        Accounting for Stock Issued to Employees,  and Related  Interpretations,
        in accounting for stock warrants issued to employees.  Under APB No. 25,
        employee  compensation  cost is recognized  when estimated fair value of
        the  underlying  stock on date of grant  exceeds  exercise  price of the
        stock option.  For stock options and warrants  issued to  non-employees,
        the  Company  applies  Statements  of  Financial   Accounting  Standards
        ("SFAS")  No.  123,  Accounting  for  Stock-Based  Compensation,   which
        requires the recognition of compensation  cost based upon the fair value
        of stock  warrants  at the grant  date  using the  Black-Scholes  option
        pricing model.

NOTE 2 INVENTORIES
-------------------

        Inventories at July 31, 2005 consisted of the following:


        Raw materials                              $             203
        Finished products                                         52
                                                   ------------------
                                                                 255
        Less provision of obsolescence                             -
                                                   ------------------

                                                                 255
                                                   ==================

NOTE 3 STOCKHOLDERS' EQUITY
---------------------------

        (A) Common Stock Issued for Cash
         --------------------------------

        During April 2005,  the Company issued 150,000 shares of common stock to
        individuals for cash of $4,500 ($0.03 per share).

        During May 2005,  the Company  issued  220,000 shares of common stock to
        individuals for cash of $6,600 ($0.03 per share).

        (B) Stock Issued for Services
         ----------------------------

        During 2004,  the Company  issued  100,000 shares of common stock to its
        founder for payment of $100 in expenses ($0.0001 per share).

        During 2005, the Company issued 28,400,000 shares of common stock to its
        principal  stockholder  for services  valued at $852,000 based on recent
        cash offering prices ($0.03 per share) (See Note 4).

                                       7
<PAGE>
                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                     NOTES TO CONDENSED FINANCIAL STATEMENTS
                               AS OF JULY 31, 2005
                               -------------------
                                   (UNAUDITED)

        (C) In-Kind Contribution
         -----------------------

        During 2005, the Company  recorded $271 of in-kind interest expense on a
        loan by the Company's principal stockholder.

        During  2005,  the  stockholder  of the Company  paid $750 of  operating
        expenses on behalf of the Company (See Note 4).

NOTE 4 RELATED PARTY TRANSACTIONS
---------------------------------

        A  stockholder  of the  Company  paid $750 of  expenses on behalf of the
        Company from inception (See Note 3).

        During 2005, the Company issued 28,400,000 shares of common stock to its
        principal  stockholder  for services  valued at $852,000 based on recent
        cash offering prices ($0.03 per share) (See Note 3).

        During 2005,  the  Company's  principal  stockholder  loaned the Company
        $36,118 (See Note 5).

NOTE 5 LOAN PAYABLE - STOCKHOLDER
---------------------------------

        During 2005, the Company's  principal  stockholder loaned $36,118 to the
        Company on an  interest-free,  due on demand basis. The Company recorded
        an in-kind interest expense using an interest rate of 3%.

NOTE 6 GOING CONCERN
--------------------

        As reflected in the accompanying financial statements, the Company is in
        the development stage with no operations.  This raises substantial doubt
        about its  ability to continue  as a going  concern.  The ability of the
        Company to continue as a going  concern is  dependent  on the  Company's
        ability to raise additional capital and implement its business plan. The
        financial  statements  do not  include  any  adjustments  that  might be
        necessary if the Company is unable to continue as a going concern.

        Management  believes  that  actions  presently  being  taken  to  obtain
        additional  funding  and  implement  its  strategic  plans  provide  the
        opportunity for the Company to continue as a going concern.


                                       9
<PAGE>
Item 2. Management's Discussion and Analysis of Financial Conditions and Results
        of Operations

Plan of Operation
-----------------

On March  25,  2005 (the  "Effective  Date"),  pursuant  to the terms of a Stock
Purchase  Agreement,  Glen  Landry  purchased  100,000  shares of our issued and
outstanding common stock from Richard Neussler,  the sole officer,  director and
shareholder  of the Company.  Glen Landry was  appointed  our  President,  Chief
Executive  Officer,  Chief  Financial  Officer,  and  Chairman  of the  Board of
Directors.  As a result of this change in control,  we have changed our business
plan to the production of cosmetics and creams.  Specifically  we will begin the
development and production of an under-eye cream that will  dramatically  reduce
the signs of aging,  such as lines and  puffiness.  The Company  will pursue the
development  of other  cosmetic  products  in the future.  On April 8, 2005,  we
amended our  Articles of  Incorporation  to change our name to Elite  Cosmetics,
Inc.

In April 2005,  we conducted a private  placement  offering  and issued  150,000
shares of common stock at a purchase price of $0.03 per share to individuals for
total cash of $4,500.  In May we finalized the offering by selling an additional
220,000  shares  of  common  stock at a  purchase  price of $0.03  per  share to
individuals for total cash of $6,600.  In total in this offering we sold a total
of 370,000 shares at $0.03 per share for a total of $11,100.

Results of Operation
--------------------

We did not have any operating  income from  inception  (August 19, 2004) through
July 31, 2005 and during this we recognized a net loss of $880,388.  We have had
no general  and  administrative  expenses  from  inception.  Our  expenses  from
inception  were  comprised  of stock  compensation  paid to our sole officer and
director.

Liquidity and Capital Resources
-------------------------------

At July 31, 2005 the  Company  had $19,696 in cash and $19,951 of total  assets,
and will  rely  upon  the  issuance  of  common  stock  and  additional  capital
contributions  from  shareholders to fund  administrative  expenses  pending the
commencement of our operations.


                                       10
<PAGE>
 Item 3. Controls and Procedures
-------------------------------

(a) Evaluation of disclosure controls and procedures.

Our Chief  Executive  Officer  and Chief  Financial  Officer  (collectively  the
"Certifying  Officers")  maintain a system of disclosure controls and procedures
that is designed to provide  reasonable  assurance  that  information,  which is
required to be disclosed,  is accumulated and communicated to management timely.
Under the supervision and with the  participation of management,  the Certifying
Officers  evaluated  the  effectiveness  of  the  design  and  operation  of our
disclosure  controls and  procedures  (as defined in Rule  [13a-14(c)/15d-14(c)]
under the Exchange  Act) within 90 days prior to the filing date of this report.
Based  upon  that  evaluation,   the  Certifying  Officers  concluded  that  our
disclosure  controls and  procedures  are  effective in timely  alerting them to
material  information  relative to our company  required to be  disclosed in our
periodic filings with the SEC.

(b) Changes in internal controls.

Our Certifying  Officer has indicated that there were no significant  changes in
our  internal  controls  or  other  factors  that  could  affect  such  controls
subsequent to the date of his evaluation, and there were no such control actions
with regard to significant deficiencies and material weaknesses.

                           PART II - OTHER INFORMATION

Item 1.   Legal Proceedings.

          We are currently not a party to any pending legal  proceedings  and no
          such  action by, or to the best of its  knowledge,  against the us has
          been threatened.

Item 2.   Changes in Securities.

          In May 2005,  the Company  issued  220,000  shares of common  stock to
          individuals for cash of $6,600 ($.03 per share).

Item 3.   Defaults Upon Senior Securities.

          None

Item 4.   Submission of Matters to a Vote of Security Holders.

          No matter was  submitted  during the  quarter  ending  July 31,  2005,
          covered  by this  report to a vote of our  shareholders,  through  the
          solicitation of proxies or otherwise.

Item 5.   Other Information.

          None

Item 6.   Exhibits and Reports of Form 8-K.

          (a)  Exhibits

          31.1 Certification pursuant to Section 302 of Sarbanes Oxley Act
               of 2002

          32.1 Certification pursuant to Section 906 of Sarbanes Oxley Act
               of 2002

          (b) Reports of Form 8-K

              On June 10, 2005, we filed a Form 8-K based on a change in
              accountant.



                                       11
<PAGE>
                                   SIGNATURES

In  accordance  with  Section 13 or 15(d) of the Exchange  Act,  the  registrant
caused  this  report to be signed on its behalf by the  undersigned,  there unto
duly authorized.

                                 Elite Cosmetics, Inc.


Date: September 13, 2005         By: /s/ Glen Landry
                                 -------------------
                                 Glen Landry
                                 President, CEO and CFO